Search
for
Sort by
Research 541–570 of 548
- Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries
- Eruptive vellus hair cyst: Treatment with topical tretinoin 0.025% cream
- Simple Method for Aesthetic Symmetrical Post Burn Reconstruction of the Temporal and Sideburn Subunits
- Calcineurin/Nuclear Factor of Activated T-Cell Pathway in Cutaneous Squamous Cell Carcinoma
- Oral Presentations
- stem cell translation and bioethics
- Health Utility Measures Among Patients with Androgenetic Alopecia After Hair Transplant
- MTHFR C677T Polymorphism and Serum Homocysteine Level as Risk Factors of Coronary Heart Disease in Patients with Androgenetic Alopecia: A Case Control Study
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Agglomerative clustering-based drugs graded for the risk signals of drug-induced cognitive disorder: a study on the FAERS database
- Case Report: Omalizumab-associated hair loss: a case of eyebrow alopecia areata, literature review and FAERS database analysis
- Assessing finasteride-associated sexual dysfunction using the FAERS database
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Assessing finasteride-associated sexual dysfunction using the FAERS database
- Drug-induced vitiligo: a real-world pharmacovigilance analysis of the FAERS database
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- (719) Signal Detection of Depression and Suicidality With the 5-Alpha Reductase Inhibitors: Evidence from the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) Database
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Abstract 4142154: Risk of Suicide, Hair Loss, and Aspiration with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Pharmacovigilance Study from the FAERS database
- Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases
- Analyzing real-world adverse events of spironolactone with the FAERS database
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- Disproportionality analysis comparing safety profiles of sonidegib and vismodegib based on the FAERS database
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real‐World Pharmacovigilance Study
- Association between finasteride with subjective memory deficits: a study from the NHANES and FAERS databases
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Suicidal behaviors (suicidal ideation, suicide attempt and completed suicide) in patients treated with finasteride for hair loss: Results from the U.S. FDA Adverse Event Reporting System (FAERS) database
- Drug-induced erectile dysfunction: a real-world pharmacovigilance study using the FDA adverse event reporting system database